117 related articles for article (PubMed ID: 31731183)
41. Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-20.
Shetty DK; Inamdar MS
Stem Cell Res; 2016 Mar; 16(2):207-9. PubMed ID: 27345969
[TBL] [Abstract][Full Text] [Related]
42. Generation of an ASS1 heterozygous knockout human embryonic stem cell line, WAe001-A-13, using CRISPR/Cas9.
Yuan F; Guo D; Liu Y; Xu Y; Gao G; Wu Y; Yang F; Ke X; Lai K; Wei H; Li YX
Stem Cell Res; 2018 Jan; 26():67-71. PubMed ID: 29247816
[TBL] [Abstract][Full Text] [Related]
43. Generation of human induced pluripotent stem cell lines from a patient with ITM2B-related retinal dystrophy and a non mutated brother.
Wohlschlegel J; Letellier C; Liu B; Méjécase C; Slembrouck-Brec A; Condroyer C; Michiels C; Sahel JA; Reichman S; Zeitz C; Goureau O; Audo I
Stem Cell Res; 2019 Dec; 41():101625. PubMed ID: 31731182
[TBL] [Abstract][Full Text] [Related]
44. Genetic Correction of Induced Pluripotent Stem Cells From a Deaf Patient With MYO7A Mutation Results in Morphologic and Functional Recovery of the Derived Hair Cell-Like Cells.
Tang ZH; Chen JR; Zheng J; Shi HS; Ding J; Qian XD; Zhang C; Chen JL; Wang CC; Li L; Chen JZ; Yin SK; Huang TS; Chen P; Guan MX; Wang JF
Stem Cells Transl Med; 2016 May; 5(5):561-71. PubMed ID: 27013738
[TBL] [Abstract][Full Text] [Related]
45. Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.
Cheng YC; Huang CY; Ho MC; Hsu YH; Syu SH; Lu HE; Lin HI; Lin CH; Hsieh PCH
Stem Cell Res; 2018 Apr; 28():1-5. PubMed ID: 29414410
[TBL] [Abstract][Full Text] [Related]
46. Non-syndromic retinitis pigmentosa due to mutations in the mucopolysaccharidosis type IIIC gene, heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT).
Haer-Wigman L; Newman H; Leibu R; Bax NM; Baris HN; Rizel L; Banin E; Massarweh A; Roosing S; Lefeber DJ; Zonneveld-Vrieling MN; Isakov O; Shomron N; Sharon D; Den Hollander AI; Hoyng CB; Cremers FP; Ben-Yosef T
Hum Mol Genet; 2015 Jul; 24(13):3742-51. PubMed ID: 25859010
[TBL] [Abstract][Full Text] [Related]
47. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
Horii T; Hatada I
Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
[TBL] [Abstract][Full Text] [Related]
48. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
Yumlu S; Bashir S; Stumm J; Kühn R
Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
[TBL] [Abstract][Full Text] [Related]
49. Generation of induced pluripotent stem cell lines carrying monoallelic (UCSFi001-A-60) or biallelic (UCSFi001-A-61; UCSFi001-A-62) frameshift variants in CACNA1A using CRISPR/Cas9.
Hommersom MP; Bijnagte-Schoenmaker C; Albert S; van de Warrenburg BPC; Nadif Kasri N; van Bokhoven H
Stem Cell Res; 2022 May; 61():102730. PubMed ID: 35286975
[TBL] [Abstract][Full Text] [Related]
50. Generation of an induced pluripotent stem cell line (CIMAi001-A) from a compound heterozygous Primary Hyperoxaluria Type I (PH1) patient carrying p.G170R and p.R122* mutations in the AGXT gene.
Martinez-Turrillas R; Rodriguez-Diaz S; Rodriguez-Marquez P; Martin-Mallo A; Salido E; Beck BB; Prosper F; Rodriguez-Madoz JR
Stem Cell Res; 2019 Dec; 41():101626. PubMed ID: 31715429
[TBL] [Abstract][Full Text] [Related]
51. A Rapid Pipeline to Model Rare Neurodevelopmental Disorders with Simultaneous CRISPR/Cas9 Gene Editing.
Bell S; Peng H; Crapper L; Kolobova I; Maussion G; Vasuta C; Yerko V; Wong TP; Ernst C
Stem Cells Transl Med; 2017 Mar; 6(3):886-896. PubMed ID: 28170165
[TBL] [Abstract][Full Text] [Related]
52. CRISPR-Cas9-Mediated Correction of the G189R-PAX2 Mutation in Induced Pluripotent Stem Cells from a Patient with Focal Segmental Glomerulosclerosis.
Trionfini P; Ciampi O; Todeschini M; Ascanelli C; Longaretti L; Perico L; Remuzzi G; Benigni A; Tomasoni S
CRISPR J; 2019 Apr; 2():108-120. PubMed ID: 30998089
[TBL] [Abstract][Full Text] [Related]
53. Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-39.
Shetty DK; Inamdar MS
Stem Cell Res; 2016 Mar; 16(2):308-10. PubMed ID: 27345991
[TBL] [Abstract][Full Text] [Related]
54. One-Step Generation of Seamless Luciferase Gene Knockin Using CRISPR/Cas9 Genome Editing in Human Pluripotent Stem Cells.
Li M; Hunt JFVS; Bhattacharyya A; Zhao X
Methods Mol Biol; 2019; 1942():61-69. PubMed ID: 30900175
[TBL] [Abstract][Full Text] [Related]
55. Effects of genetic correction on the differentiation of hair cell-like cells from iPSCs with MYO15A mutation.
Chen JR; Tang ZH; Zheng J; Shi HS; Ding J; Qian XD; Zhang C; Chen JL; Wang CC; Li L; Chen JZ; Yin SK; Shao JZ; Huang TS; Chen P; Guan MX; Wang JF
Cell Death Differ; 2016 Aug; 23(8):1347-57. PubMed ID: 26915297
[TBL] [Abstract][Full Text] [Related]
56. A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.
Cai L; Bai H; Mahairaki V; Gao Y; He C; Wen Y; Jin YC; Wang Y; Pan RL; Qasba A; Ye Z; Cheng L
Stem Cells Transl Med; 2018 Jan; 7(1):87-97. PubMed ID: 29164808
[TBL] [Abstract][Full Text] [Related]
57. Production and characterization of CSSI003 (2961) human induced pluripotent stem cells (iPSCs) carrying a novel puntiform mutation in RAI1 gene, Causative of Smith-Magenis syndrome.
Altieri F; Turco EM; Vinci E; Torres B; Ferrari D; De Jaco A; Mazzoccoli G; Lamorte G; Nardone A; Della Monica M; Bernardini L; Vescovi AL; Rosati J
Stem Cell Res; 2018 Apr; 28():153-156. PubMed ID: 29494847
[TBL] [Abstract][Full Text] [Related]
58. Generation of a CLTA reporter human induced pluripotent stem cell line, CRMi001-A-1, using the CRISPR/Cas9 system to monitor endogenous clathrin trafficking.
Anderson RH; Kerkvliet JG; Otta JJ; Ross AD; Leiferman PC; Hoppe AD; Francis KR
Stem Cell Res; 2018 Dec; 33():95-99. PubMed ID: 30340091
[TBL] [Abstract][Full Text] [Related]
59. Effective CRISPR/Cas9-based nucleotide editing in zebrafish to model human genetic cardiovascular disorders.
Tessadori F; Roessler HI; Savelberg SMC; Chocron S; Kamel SM; Duran KJ; van Haelst MM; van Haaften G; Bakkers J
Dis Model Mech; 2018 Oct; 11(10):. PubMed ID: 30355756
[TBL] [Abstract][Full Text] [Related]
60. CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer's PSEN2
Ortiz-Virumbrales M; Moreno CL; Kruglikov I; Marazuela P; Sproul A; Jacob S; Zimmer M; Paull D; Zhang B; Schadt EE; Ehrlich ME; Tanzi RE; Arancio O; Noggle S; Gandy S
Acta Neuropathol Commun; 2017 Oct; 5(1):77. PubMed ID: 29078805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
